Evidence map›Paper›PMID 20967221›Full record

ArticlePloS one2010

AGT M235T genotype/anxiety interaction and gender in the HyperGEN study.

Sarah S Knox, Xinxin Guo, Yuqing Zhang, G Weidner, Scott Williams, R Curtis Ellison

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Sarah S KnoxDepartment of Community Medicine, Mary Babb Randolf Cancer Center, West Virginia University School of Medicine, Morgontown, West Virginia, United States of America. sknox@hsc.wvu.edu
Xinxin Guo
Yuqing Zhang
G Weidner
Scott Williams
R Curtis Ellison
Boston University · USHealth Outcomes Solutions (United States) · USSan Francisco State University · USVanderbilt University · USWest Virginia University Hospitals · US

Funding

The Family Blood Pressure Program (Program Data Center)U01HL054473 · NHLBI · WASHINGTON UNIVERSITY · PI RAO, DABEERU C · 2000 to 2008
$5.8M
NHLBI FAMILY BLOOD PRESSURE PROGRAM-HYPERGEN-MPLS FCU01HL054496 · NHLBI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI PANKOW, JAMES S · 2000 to 2004
$3.2M
HYPERGEN - BIRMINGHAM FIELD CENTERU01HL054495 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LEWIS, CORA E · 2000 to 2004
$923k
HYPERGEN CENTRAL BIOCHEMISTRY LABORATORYU01HL054472 · NHLBI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI ECKFELDT, JOHN H · 2000 to 2004
$879k
HYPERGEN-NCU01HL054509 · NHLBI · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI NORTH, KARI E · 2000 to 2004
$640k
HYPERGEN-BOSTON UNIVERSITY/FRAMINGHAM FIELD CENTERU01HL054497 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ELLISON, CURTIS R. · 2000 to 2004
$430k
HYPERGENU10HL054509 · NHLBI · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI HEISS, GERARDO · 1995 to 1999
–
GENETIC DETERMINANTS OF HIGH BLOOD PRESSUREU10HL054515 · NHLBI · UNIVERSITY OF UTAH · PI LALOUEL, JEAN-MARC · 1995 to 1999
–
HYPERGENU10HL054472 · NHLBI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI ECKFELDT, JOHN H · 1995 to 1999
–
HYPERGEN- DATA COORDINATING CENTERU10HL054473 · NHLBI · WASHINGTON UNIVERSITY · PI RAO, DABEERU C · 1995 to 1999
–
HYPERGENU10HL054495 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI OBERMAN, ALBERT J · 1995 to 1999
–
HYPERGENU10HL054496 · NHLBI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI ARNETT, DONNA K. · 1995 to 1999
–
NHLBI NIH HHS U01 HL054472NHLBI NIH HHS U01 HL054473NHLBI NIH HHS U01 HL054495NHLBI NIH HHS U01 HL054496NHLBI NIH HHS U01 HL054497NHLBI NIH HHS U01 HL054509NHLBI NIH HHS U10 HL054472NHLBI NIH HHS U10 HL054473NHLBI NIH HHS U10 HL054495NHLBI NIH HHS U10 HL054496NHLBI NIH HHS U10 HL054497NHLBI NIH HHS U10 HL054509NHLBI NIH HHS U10 HL544471NHLBI NIH HHS U10 HL54472NHLBI NIH HHS U10 HL54473NHLBI NIH HHS U10 HL54495NHLBI NIH HHS U10 HL54496NHLBI NIH HHS U10 HL54497NHLBI NIH HHS U10 HL54509NHLBI NIH HHS U10 HL54515
6 · The paper itself

Abstract

backgroundBoth anxiety and elevated heart rate (HR) have been implicated in the development of hypertension. The HyperGen cohort, consisting of siblings with severe and mild hypertension, an age-matched random sample of persons from the same base populations, and unmedicated adult offspring of the hypertensive siblings (N = 1,002 men and 987 women), was analyzed for an association of the angiotenisinogen AGTM235T genotype (TT, MT, MM) with an endophenotype, heart rate (HR) in high and low anxious groups. METHODOLOGY: The interaction of AGTM genotype with anxiety, which has been independently associated with hypertension, was investigated adjusting for age, hypertension status, smoking, alcohol consumption, beta blocker medication, body mass index, physical activity and hours of television viewing (sedentary life style). PRINCIPAL

findingsAlthough there was no main effect of genotype on HR in men or women, high anxious men with the TT genotype had high HR, whereas high anxious men with the MM genotype had low HR. In women, HR was inversely associated with anxiety but there was no interaction with genotype. CONCLUSION/SIGNIFICANCE: The results suggest that high anxiety in men with the TT genotype may increase risk for hypertension whereas the MM genotype may be protective in high anxious men. This type of gene x environment interaction may be one reason why genome wide association studies sometimes fail to replicate. The locus may be important only in combination with certain environmental factors.

Indexed as

Sex FactorsAngiotensinogenAnxietyCohort StudiesFemaleGenotypeHeart RateHumansHypertensionLife StyleMaleAngiotensinogen

Identifiers

PMID20967221
PMCPMC2954179
OpenAlexW1964285939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.